Cargando…

DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage

DNA damage-inducing therapies are of tremendous value for cancer treatment and function by the direct or indirect formation of DNA lesions and subsequent inhibition of cellular proliferation. Of central importance in the cellular response to therapy-induced DNA damage is the DNA damage response (DDR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reuvers, Thom G. A., Kanaar, Roland, Nonnekens, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463878/ https://www.ncbi.nlm.nih.gov/pubmed/32731592 http://dx.doi.org/10.3390/cancers12082098

Ejemplares similares

DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivo
por: Reuvers, Thom G.A., et al.
Publicado: (2023)

Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
por: Huang, Jau-Ling, et al.
Publicado: (2022)

Role of the DNA damage response in prostate cancer formation, progression and treatment
por: Zhang, Wenhao, et al.
Publicado: (2019)

Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
por: Xu, Yang, et al.
Publicado: (2015)

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies
por: Molinaro, Caroline, et al.
Publicado: (2021)

Roles of DNA damage repair and precise targeted therapy in renal cancer (Review)
por: Lai, Yongchang, et al.
Publicado: (2022)

Modeling Early Radiation DNA Damage Occurring During (177)Lu-DOTATATE Radionuclide Therapy
por: Tamborino, Giulia, et al.
Publicado: (2022)

Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment
por: Zhang, Wenhao, et al.
Publicado: (2019)

Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage
por: Choi, Kyu Jin, et al.
Publicado: (2020)

Imaging DNA Damage Repair In Vivo After (177)Lu-DOTATATE Therapy
por: O’Neill, Edward, et al.
Publicado: (2020)

DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors
por: Laranjeira, Angelo B. A., et al.
Publicado: (2023)

Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival
por: Tamborino, Giulia, et al.
Publicado: (2022)

Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target
por: Raimundo, Liliana, et al.
Publicado: (2021)

Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy
por: Sun, Jiaao, et al.
Publicado: (2023)

Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system
por: Buoninfante, Olimpia Alessandra, et al.
Publicado: (2018)

MERIT40-dependent recruitment of tankyrase to damaged DNA and its implication for cell sensitivity to DNA-damaging anticancer drugs
por: Okamoto, Keiji, et al.
Publicado: (2018)

Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023)

Microscopy-based single-cell proteomic profiling reveals heterogeneity in DNA damage response dynamics
por: Su, Pin-Rui, et al.
Publicado: (2022)

Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments
por: Scutigliani, Enzo M., et al.
Publicado: (2021)

Targeting DNA damage response in cancer therapy
por: Hosoya, Noriko, et al.
Publicado: (2014)

Targeting the DNA damage response for cancer therapy
por: Curtin, Nicola J.
Publicado: (2023)

DNA Damaged Induced Cell Death in Oocytes
por: Gebel, Jakob, et al.
Publicado: (2020)

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
por: Zimmer, Yitzhak, et al.
Publicado: (2020)

Precision medicine meets the DNA damage response in pancreatic cancer
por: Perkhofer, Lukas, et al.
Publicado: (2018)

DNA Damage: From Threat to Treatment
por: Carusillo, Antonio, et al.
Publicado: (2020)

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
por: Clark, Curtis A., et al.
Publicado: (2022)

Damaged-DNA Binding Protein-2 Drives Apoptosis Following DNA Damage
por: Bagchi, Srilata, et al.
Publicado: (2010)

Harnessing the Nucleolar DNA Damage Response in Cancer Therapy
por: Xuan, Jiachen, et al.
Publicado: (2021)

DNA repair and damage pathways in mesothelioma development and therapy
por: Malakoti, Faezeh, et al.
Publicado: (2022)

Interplay of space radiation and microgravity in DNA damage and DNA damage response
por: Moreno-Villanueva, María, et al.
Publicado: (2017)

Cellular Responses to Cisplatin-Induced DNA Damage
por: Basu, Alakananda, et al.
Publicado: (2010)

Carcinogens and DNA damage
por: Barnes, Jessica L., et al.
Publicado: (2018)

Exploiting DNA repair defects for novel cancer therapies
por: van Gent, Dik C., et al.
Publicado: (2016)

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
por: Jurkovicova, Dana, et al.
Publicado: (2022)

DNA Damage Response and Repair in Boron Neutron Capture Therapy
por: Mechetin, Grigory V., et al.
Publicado: (2023)

Tau and DNA Damage in Neurodegeneration
por: Colnaghi, Luca, et al.
Publicado: (2020)

Sumoylation and the DNA Damage Response
por: Cremona, Catherine A., et al.
Publicado: (2012)

Autophagy in DNA Damage Response
por: Czarny, Piotr, et al.
Publicado: (2015)

DNA Damage and Pulmonary Hypertension
por: Ranchoux, Benoît, et al.
Publicado: (2016)

FANCD2 and DNA Damage
por: Nepal, Manoj, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qc3fcmm4hoib35q6hqbq2tl3bg